Procter & Gamble Health Ltd.

5073.05 -19.10 ▼-0.4%

05 March 2024, 09:07:25 AM
Volume: 2

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.pghealthindia.com
Market Cap 8,459.05 Cr.
Enterprise Value(EV) 8,033.49 Cr. 2023-12
Financial Indicators
Earnings per share (EPS) 136.54 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 37.32 Trailing Twelve Months Ending 2023-12
Industry PE 41.59 Trailing Twelve Months Ending 2023-12
Book Value / Share 485.49 Trailing Twelve Months Ending 2023-12
Price to Book Value 10.50 Calculated using Price: 5,096.00
Dividend Yield 1.86 Period Ending 2023-06
No. of Shares Subscribed 1.66 Cr. 16,599,382 Shares
FaceValue 10
About Procter & Gamble Health Ltd.
Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country. The company is one of India's largest VMS Companies manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle and improved quality of life. Its trusted products are household names in India protecting and supporting millions of people at every stage of life.

Procter & Gamble Health Ltd. Delivery

Delivered Qty
Traded Qty

Procter & Gamble Health Ltd. Performance

1 Day
-0.38%
1 Week
-0.36%
1 Month
-2.20%
3 Month
-1.89%
6 Month
+1.38%
1 Year
+1.92%
2 Year
+12.68%
5 Year
+55.68%
10 Year
+756.43%

Procter & Gamble Health Ltd. Fundamental Ratios

9 years 2014-12 2015-12 2016-12 2017-12 2018-12 2020-06 2021-06 2022-06 2023-06
Return on Equity (%) 8.02 9.35 12.61 8.74 8.95 20.79 22.04 29.41 33.94
Return on Capital Employed (%) 12.36 14.54 18.35 14.16 13.9 29.01 29.08 38.45 46.07
Return on Assets (%) 4.37 3.92 5.48 4.24 4.96 10.82 8.65 9.83 11

Procter & Gamble Health Ltd. Balance Sheet

Particulars 10 years 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2020-06 Rs. Cr. 2021-06 Rs. Cr. 2022-06 Rs. Cr. 2023-06 Rs. Cr. 2023-12* Rs. Cr.
Shh. Funds 554 592 664 733 1,540 906 704 616 751 806
Non Curr. Liab. 390 395 399 431 495 667 723 714 803 14
Curr. Liab. 260 539 301 352 548 539 551 608 679 231
Minority Int.
Equity & Liab. 1,204 1,525 1,363 1,516 2,583 2,112 1,978 1,938 2,233 1,050
Non Curr. Assets 581 579 613 637 693 847 939 954 1,062 279
Curr. Assets 623 946 750 879 1,889 1,265 1,039 984 1,171 771
Misc. Exp. not W/O
Total Assets 1,204 1,525 1,363 1,516 2,583 2,112 1,978 1,938 2,233 1,050

Procter & Gamble Health Ltd. Profit and Loss

Particulars 10 years 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2020-06 Rs. Cr. 2021-06 Rs. Cr. 2022-06 Rs. Cr. 2023-06 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 867 940 993 698 849 1,356 1,009 1,114 1,230 1,237
Other Income 20 23 24 30 28 70 18 13 18 22
Total Income 888 963 1,017 729 877 1,426 1,027 1,128 1,248 1,259
Total Expenditure -809 -856 -877 -628 -705 -1,042 -763 -847 -905 -922
PBIDT 79 107 140 101 173 384 264 281 343 337
Interest -1 0 -1 -1
Depreciation -13 -23 -25 -19 -21 -29 -30 -27 -28 -26
Taxation -23 -30 -36 -38 -56 -101 -56 -61 -85 -84
Exceptional Items 17 7
PAT 43 54 79 61 102 254 177 193 229 227
Adjusted EPS 26 32 48 37 61 153 107 116 138 137

Procter & Gamble Health Ltd. Cash Flow

Particulars 10 years 2013-12 Rs. Cr. 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2020-06 Rs. Cr. 2021-06 Rs. Cr. 2022-06 Rs. Cr. 2023-06 Rs. Cr.
Cash Fr. Operatn. 0 5 83 107 54 -130 235 247 170 236
Cash Fr. Inv. 7 11 -68 -75 -48 1,270 165 -32 -26 -22
Cash Fr. Finan. -5 -17 -12 -15 -22 -30 -883 -387 -289 -98
Net Change 3 -1 4 17 -16 1,109 -483 -172 -145 116
Cash & Cash Eqvt 7 5 9 26 10 1,119 636 464 319 435

Procter & Gamble Health Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 51.82 51.82 51.82 51.85 51.82 51.82 51.82 51.82 51.82
Public 48.18 48.18 48.18 48.15 48.18 48.18 48.18 48.18 48.18
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Procter & Gamble Health Ltd. Announcements

Mon, 04 Mar 2024
Loss of Share Certificates
Procter & Gamble Health Limited has informed the Exchange about Loss of Share Certificates
Mon, 04 Mar 2024
Loss/Duplicate-Share Certificate-XBRL
Procter & Gamble Health Limited has informed the Exchange about Loss of share certificates
Tue, 27 Feb 2024
Loss of Share Certificates
Procter & Gamble Health Limited has informed the Exchange about Loss of Share Certificates

Procter & Gamble Health Ltd. Technical Scans

Mon, 04 Mar 2024
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Closing Near 100 SMA Closing Near 100 SMA

Procter & Gamble Health Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 372,436.77 1,553.80 +0.1%
Cipla Ltd. 118,783.64 1,465.15 -0.4%
Dr. Reddy's Laboratories Ltd. 105,691.98 6,334.90 0.0%
Zydus Lifesciences Ltd. 95,764.63 953.00 +0.7%
Divi's Laboratories Ltd. 92,421.56 3,484.60 +0.1%
Torrent Pharmaceuticals Ltd. 91,038.44 2,690.85 0.0%
Apollo Hospitals Enterprise Ltd. 86,787.70 6,035.05 +0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.82 1,553.80 +0.1%
Cipla Ltd. Consolidated 2023-12 32.03 1,465.15 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.22 6,334.90 0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.20 953.00 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-12 66.83 3,484.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.94 2,690.85 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 109.95 6,035.05 +0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.97 1,553.80 +0.1%
Cipla Ltd. Consolidated 2023-12 4.59 1,465.15 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.93 6,334.90 0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.93 953.00 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-12 7.09 3,484.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.73 2,690.85 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 12.85 6,035.05 +0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,553.80 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,465.15 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,334.90 0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 953.00 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,484.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,690.85 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,035.05 +0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,553.80 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,465.15 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,334.90 0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 953.00 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,484.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,690.85 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,035.05 +0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,553.80 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,465.15 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,334.90 0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 953.00 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,484.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,690.85 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,035.05 +0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,553.80 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,465.15 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,334.90 0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 953.00 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,484.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,690.85 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,035.05 +0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,553.80 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,465.15 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,334.90 0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 953.00 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,484.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,690.85 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,035.05 +0.0%

Procter & Gamble Health Ltd. FAQ's

What is Procter&Gamble Healt share price?

Can I buy Procter&Gamble Healt shares now?

What is the Dividend Yield of Procter&Gamble Healt?

What is the Market Cap of Procter&Gamble Healt?

What are the key metrics to analyse Procter&Gamble Healt?

What is the 52 Week High and Low of Procter&Gamble Healt?

What is the trend of Procter&Gamble Healt share price?